Prospective validation demonstrates clinical-grade accuracy with substantially shorter measurements with the BP2000.

OKLAHOMA CITY, Nov. 10, 2026 /PRNewswire/ -- Biozen, LLC has made clinically accurate blood pressure measurement even faster, without a traditional cuff or calibration.

At the American Heart Association's Scientific Sessions 2026 in Chicago, Biozen Chief Scientific Officer Omer Inan, PhD, presented new research on the company's BP2000, a next-generation version of the FDA-cleared BP1000.

The latest iteration reduces average measurement time by 40% while maintaining accurate systolic and diastolic blood pressure measurements.

The findings were supported by a prospective clinical study involving 85 participants and 255 measurements, using a validation protocol based on ISO 81060-2:2018.

Faster measurement times make accurate blood pressure monitoring more practical and convenient for everyday use, bringing clinical-grade measurement closer to becoming a seamless part of everyday life.

"FDA clearance of our first device was a milestone, not the finish line," said Dikran Tourian, Chief Executive Officer of Biozen. "We've established the foundation. Now we're focused on how far we can take this technology."

"Speed means little without accuracy," said Inan. "We've reduced measurement time by 40% while preserving the accuracy that defines our technology."

Biozen's proprietary platform is engineered for integration across wearables, smartphones and connected health technologies, positioning the company to bring clinical-grade blood pressure measurement beyond standalone devices.

About Biozen

Redefining how the world measures blood pressure.

Biozen is a privately held digital health company headquartered in Oklahoma City, Oklahoma, with research and development in Atlanta, Georgia. The company's cuffless blood pressure platform — protected by more than 68 granted U.S. and international patents — integrates advanced biosensors with proprietary algorithms to deliver calibration-free, clinical-grade blood pressure readings at the fingertip.

Note: BP2000 is an investigational device. Limited by Federal law to investigational use. 

For more information, visit biozen.com.

Media Contact

Ashley Wilson
aw@biozen.com
+1 405-413-5201

View original content to download multimedia:https://www.prnewswire.com/news-releases/biozen-cuts-cuffless-blood-pressure-measurement-time-by-40-while-maintaining-accuracy-302934984.html

SOURCE Biozen, LLC